Kathleen Pfaff

10PUBLICATIONS
168CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMedical molecular engineering of nucleic acids and proteinsMolecular targetsAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 20, 2025
Phase II Trial of Cabozantinib in Combination with Nivolumab for Advanced Extrapancreatic Neuroendocrine Tumors.

Kimberly J Perez, Nora Horick, Joanna Baginksa

|Sep 04, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors.

Joao V Alessi, James R Lindsay, Anita Giobbie-Hurder

|Apr 11, 2025
First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell-Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Patients with Metastatic Melanoma.

F Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie

|Dec 13, 2024
Next-Generation Sequencing-Based MSI Scoring Predicts Benefit in Mismatch Repair-Deficient Tumors Treated with Nivolumab: Follow-up on NCI-MATCH Arm Z1D.

Jonathan D Schoenfeld, Nilofer S Azad, Jacob Gross

|Sep 30, 2024
A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer.

Brandon M Huffman, Osama E Rahma, Kevin Tyan

|Jan 23, 2024
A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneity.

Anand G Patel, Orr Ashenberg, Natalie B Collins

Pageof 2

Frequent Collaborators

7 joint publications

Scott Rodig

4 joint publications

Jason Weirather

4 joint publications

Anita Giobbie-Hurder

3 joint publications

F Stephen Hodi